GBS Inc. to Present Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Update on August 11

Rhea-AI Summary

GBS Inc. (Nasdaq: GBS) will release its financial results for the fourth quarter and full year ended June 30, 2021, on August 11, after market close. A conference call will follow at 4:30 p.m. ET to discuss the results. GBS specializes in developing non-invasive, real-time diagnostic testing solutions for diabetes management. Stakeholders are encouraged to participate via the provided links and phone numbers for the toll-free and international lines. The webcast will be available for replay on the company's website.

Positive

• Developing innovative, non-invasive diagnostic tests for diabetes management.
• Anticipated financial results release could indicate potential growth opportunities.

Negative

• None.

- Company to Host Conference Call & Webcast at 4:30 p.m. ET -

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the fourth quarter and full year ended June 30, 2021, shortly after the NASDAQ market close on Wednesday, August 11. Management will then host a conference call and webcast at 4:30 p.m. ET.

Title:	GBS,Inc. Fourth Quarter 2021 and Full Year Financial Results Conference Call & Webcast
Date:	Wednesday, August 11, 2021
Time:	4:30 p.m. ET
Conference Call Details:	Toll-Free: 877-407-3982 International: 201-493-6780 Conference ID: 13721414
The conference call will be webcast live from the Company’s website and will be available via the following links:
Webcast:	http://public.viavid.com/index.php?id=145701 https://investors.gbs.inc/news-and-events/investor-calendar
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company’s website.

About GBS Inc.
GBS Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help people living with diabetes.

For more information, please visit GBS.inc or follow GBS Inc. on Twitter and LinkedIn.        

Investor Contact:
LifeSci Advisors, LLC
Jeremy Feffer - Managing Director
212-915-2568
jeremy@lifesciadvisors.com

Company Contact:
The iQ Group Global
Alex Arzeno - VP Investor Relations
alex.arzeno@theiqgroupglobal.com

 

FAQ

What date is GBS Inc.'s fourth quarter financial results being released?

GBS Inc. will release its fourth quarter financial results on August 11, 2021.

What time is the GBS Inc. conference call for the fourth quarter results?

The conference call for GBS Inc. will be held at 4:30 p.m. ET on August 11, 2021.

How can I access the GBS Inc. conference call?

You can access the GBS Inc. conference call via toll-free number 877-407-3982 or international number 201-493-6780.

What is the focus of GBS Inc.'s business?

GBS Inc. focuses on non-invasive, real-time diagnostic testing for diabetes management.

Where can I find the webcast for GBS Inc.'s conference call?

The webcast for GBS Inc.'s conference call will be available on their official website.